Trial Profile
Genetic determinanats of cardiovascular risk factors: comparison of efficacy and safety of ezetimibe or statin monotherapy to co-administration of both
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Simvastatin
- Indications Lipid metabolism disorders
- Focus Biomarker; Therapeutic Use
- 04 Dec 2009 Results have been published in the Journal of Clinical Endocrinology and Metabolism.
- 03 Jul 2007 New trial record.